← Leaderboards
Wanqing Liu
University Of Chicago
$6,149,849
Attributed
$8,210,495
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,210,495 · 7
By mechanism
R01$5,437,114 · 3
UT2$1,959,401 · 1
R21$426,660 · 1
T32$231,320 · 1
R03$156,000 · 1
Top collaborators
- Andrea E Cassidy-Bushrow3 shared
- Charles Larry Bisgaier2 shared
- Douglas M Ruden1 shared
- Fredrick Ray Schumacher1 shared
- Scott Matthew Williams1 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Kathryn Elizabeth Keenan$24,553,655
- Eugene B Chang$58,954,761
- Hans Schreiber$12,391,832
- Xiaoxi Zhuang$15,074,334
- Godfrey Shalom Getz$14,110,089
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesAllelesVariantLiverGeneticPharmaceutical PreparationsNonalcoholic SteatohepatitisHistologyFibrosisSuccessHepaticMediatingGenome Wide Association StudyGenetic Risk FactorChronicChronic Liver DiseaseMouse ModelGenetic PolymorphismKnock-DownTreatment StrategyDesignInflammationNon-Alcoholic Fatty Liver DiseaseDisease Phenotype
Grant awards (20)
Interaction between Genome and Heavy Metals in Nonalcoholic Fatty Liver Disease$586,862
R01 · FY2025 · ES · contact PI
PIGE: The Program Integrating Genomics and the Environment$231,320
T32 · FY2025 · ES
A Precision Medicine for Alcohol-Associated Liver Disease$982,659
UT2 · FY2024 · AA · contact PI
Interaction between Genome and Heavy Metals in Nonalcoholic Fatty Liver Disease$597,081
R01 · FY2024 · ES · contact PI
A Precision Targeted Therapeutics for Nonalcoholic Fatty Liver Disease$403,158
R01 · FY2024 · DK · contact PI
A Precision Medicine for Alcohol-Associated Liver Disease$976,742
UT2 · FY2023 · AA · contact PI
Interaction between Genome and Heavy Metals in Nonalcoholic Fatty Liver Disease$630,969
R01 · FY2023 · ES · contact PI
A Precision Targeted Therapeutics for Nonalcoholic Fatty Liver Disease$419,955
R01 · FY2023 · DK · contact PI
A Precision Targeted Therapeutics for Nonalcoholic Fatty Liver Disease$427,741
R01 · FY2022 · DK · contact PI
A Precision Targeted Therapeutics for Nonalcoholic Fatty Liver Disease$442,525
R01 · FY2021 · DK · contact PI
Fatty Acid Desaturase 1 (FADS1) Variants and Non-alcoholic Fatty Liver Disease$373,090
R01 · FY2020 · DK · contact PI
Fatty Acid Desaturase 1 (FADS1) Variants and Non-alcoholic Fatty Liver Disease$372,803
R01 · FY2019 · DK · contact PI
Fatty Acid Desaturase 1 (FADS1) Variants and Non-alcoholic Fatty Liver Disease$371,026
R01 · FY2018 · DK · contact PI
Fatty Acid Desaturase 1 (FADS1) Variants and Non-alcoholic Fatty Liver Disease$406,856
R01 · FY2017 · DK · contact PI
Fatty Acid Desaturase 1 (FADS1) Variants and Non-alcoholic Fatty Liver Disease$405,048
R01 · FY2016 · DK · contact PI
An integrated genomic and lipidomic approach to human hepatic fat accumulation$204,652
R21 · FY2011 · DK · contact PI
An integrated genomic and lipidomic approach to human hepatic fat accumulation$27,008
R21 · FY2011 · DK · contact PI
An integrated genomic and lipidomic approach to human hepatic fat accumulation$195,000
R21 · FY2010 · DK · contact PI
Genetic Role of EGFR pathway in Interstitial Lung Disease$78,000
R03 · FY2010 · HL · contact PI
Genetic Role of EGFR pathway in Interstitial Lung Disease$78,000
R03 · FY2009 · HL · contact PI